Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbazoles | 6 | 2019 | 49 | 1.880 |
Why?
|
| rac1 GTP-Binding Protein | 4 | 2018 | 50 | 1.050 |
Why?
|
| Pyrimidines | 5 | 2017 | 139 | 1.010 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 1019 | 0.920 |
Why?
|
| Drug Design | 3 | 2018 | 186 | 0.600 |
Why?
|
| Indoles | 1 | 2019 | 187 | 0.540 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2015 | 26 | 0.540 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 25 | 0.520 |
Why?
|
| Trimethylsilyl Compounds | 2 | 2006 | 5 | 0.490 |
Why?
|
| Methanol | 2 | 2006 | 22 | 0.490 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 139 | 0.480 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 1723 | 0.420 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 465 | 0.380 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 241 | 0.380 |
Why?
|
| Aminoquinolines | 2 | 2012 | 17 | 0.360 |
Why?
|
| Cell Movement | 3 | 2019 | 655 | 0.320 |
Why?
|
| Alkanes | 2 | 2006 | 14 | 0.300 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1455 | 0.270 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 2676 | 0.260 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 506 | 0.260 |
Why?
|
| Propanols | 1 | 2006 | 6 | 0.250 |
Why?
|
| Ketones | 1 | 2006 | 18 | 0.250 |
Why?
|
| Alkynes | 1 | 2006 | 52 | 0.250 |
Why?
|
| Molecular Structure | 3 | 2019 | 570 | 0.240 |
Why?
|
| Aldehydes | 1 | 2005 | 70 | 0.230 |
Why?
|
| Pharmaceutical Services | 1 | 2024 | 25 | 0.200 |
Why?
|
| Pharmacy | 1 | 2024 | 34 | 0.200 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 237 | 0.190 |
Why?
|
| Education, Pharmacy | 1 | 2024 | 57 | 0.190 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 458 | 0.160 |
Why?
|
| Warfarin | 1 | 2019 | 67 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2019 | 122 | 0.140 |
Why?
|
| Binding Sites | 2 | 2018 | 671 | 0.140 |
Why?
|
| Stereoisomerism | 3 | 2006 | 169 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 423 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1124 | 0.120 |
Why?
|
| Cell Survival | 2 | 2017 | 945 | 0.120 |
Why?
|
| Catalysis | 2 | 2006 | 187 | 0.120 |
Why?
|
| Humans | 8 | 2024 | 43102 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 863 | 0.110 |
Why?
|
| Mice | 2 | 2017 | 6644 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 317 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2015 | 408 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 611 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1081 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 157 | 0.080 |
Why?
|
| Animals | 3 | 2017 | 16992 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 508 | 0.080 |
Why?
|
| Female | 4 | 2019 | 24698 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.070 |
Why?
|
| Imines | 1 | 2006 | 9 | 0.060 |
Why?
|
| Organosilicon Compounds | 1 | 2006 | 4 | 0.060 |
Why?
|
| Boron Compounds | 1 | 2006 | 18 | 0.060 |
Why?
|
| Amines | 1 | 2006 | 41 | 0.060 |
Why?
|
| Allyl Compounds | 1 | 2006 | 55 | 0.060 |
Why?
|
| Learning | 1 | 2024 | 161 | 0.050 |
Why?
|
| Curriculum | 1 | 2024 | 318 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 67 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2019 | 206 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 800 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2013 | 21 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2544 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2012 | 28 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 296 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2006 | 155 | 0.020 |
Why?
|
| Male | 1 | 2019 | 23409 | 0.010 |
Why?
|